Long-term outcomes of laparoscopic antireflux surgery for gastroesophageal reflux disease (GERD)-related airway disorder

  • J. A. Kaufman
  • J. E. Houghland
  • E. Quiroga
  • M. Cahill
  • C. A. Pellegrini
  • B. K. Oelschlager


A strong link exists between gastroesophageal reflux disease (GERD) and airway diseases. Surgical therapy has been recommended as it is more effective than medical therapy in the short term, but there is little data on the effectiveness of surgery long-term. We analyzed the long-term response of GERD-related airway disease after laparoscopic anti-reflux surgery (LARS).


In 2004, we contacted 128 patients with airway symptoms and GERD who underwent laparoscopic antireflux surgery (LARS) between 12/1993 and 12/2002. At median follow-up of 53 months (19–110 mo) we studied the effects on symptoms, esophageal acid exposure, and medication use and we analyzed the data to determine predictors of successful resolution of airway symptoms.


Cough, hoarseness, wheezing, sore throat, and dyspnea improved in 65-75% of patients. Heartburn improved in 91 % (105/116) of patients and regurgitation in 92% (90/98). The response rate for airway symptoms was the same in patients with and without heartburn. Almost every patient took proton pump inhibitors (PPIs) preoperatively (99%, 127/128) and 61% (n = 78) were taking double or triple dose. Postoperatively, 33% (n = 45) of patients were using daily anti-acid therapy but no one was on double dose. The only factor that predicted a successful surgical outcome was the presence of abnormal reflux in the pharynx as determined by 24-hour pharyngeal pH monitoring. One hundred eleven (87%) patients rated their results as excellent (n = 78, 57%) or good (n = 33, 24%).


LARS provides an effective and durable barrier to reflux, and in so doing improves GERD-related airway symptoms in ∼70% of patients and improves typical GERD symptoms in ∼90% of patients. Pharyngeal pH monitoring identifies those patients more likely to benefit from LARS, but better diagnostic tools are needed to improve the response of airway symptoms to that of typical esophageal symptoms.


Oesophageal Clinical papers Trials Research Digestive GORD GERD (Gastro-oesophageal reflux disease) General Oesophageal 



This research was supported by the Dennis and Mary Wise Fund for esophageal research.


  1. 1.
    Delaney BC (2004) Review article: prevalence and epidemiology of gastroesophageal reflux disease. Aliment Pharmacol Ther 20 (Suppl 8): 2–4PubMedCrossRefGoogle Scholar
  2. 2.
    Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Molton LJ III (1997) Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmstead County, Minnesota. Gastroenterology 112: 1148–1156CrossRefGoogle Scholar
  3. 3.
    Srinivasan R, Tutuian R, Schoenfeld P, Vela MF, Castell JA, Isaac T, Galaria I, Katz PO, Castell DO (2004) Profile of GERD in the adult population of a northeast urban community. J Clin Gastroenterol 38: 651–657PubMedCrossRefGoogle Scholar
  4. 4.
    Jaspersen D, Kulig M, Labenz J, Leodolter A, Lind T, Meyer-Sabellek W, Vieth M, Willich SN, Linder D, Stolte M, Malfertheiner P (2003) Prevalence of extra esophageal manifestations in gastroesophageal reflux disease: an analysis based on the ProGERD study. Aliment Pharmacol Ther 17: 1515–1520PubMedCrossRefGoogle Scholar
  5. 5.
    Koufman JA (1991) The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 101(4 Pt 2 Suppl 53): 1–78PubMedGoogle Scholar
  6. 6.
    Simpson WG (1995) Gastroesophageal reflux disease and asthma: diagnosis and management. Arch Intern Med 155: 798–803PubMedCrossRefGoogle Scholar
  7. 7.
    Field SK, Sutherland LR (1998) Does medical antireflux therapy improve asthma in asthmatics with gastroesophageal reflux? A critical review of the literature. Chest 114: 275–283PubMedGoogle Scholar
  8. 8.
    Gadenstatter M, Wykypiel H, Schwab GP, Profanter C, Wetscher GJ (1999) Respiratory symptoms and dysphagia in patients with gastroesophageal reflux disease: a comparison of medical and surgical therapy. Langenbecks Arch Surg 384: 563–567PubMedCrossRefGoogle Scholar
  9. 9.
    Ours TM, Kavuru MS, Schilz RJ, Richter JE (1999) A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol 94: 3131–3138PubMedCrossRefGoogle Scholar
  10. 10.
    Johnson WE, Hagen JA, DeMeester TR, Kauer WK, Ritter MP, Peters JH, Bremner CG (1996) Outcome of respiratory symptoms after antireflux surgery on patients with gastroesophageal reflux disease. Arch Surg 131: 489–492PubMedGoogle Scholar
  11. 11.
    Farrell TM, Richardson WS, Trus TL, Smith CD, Hunter JG (2001) Response of atypical symptoms of gastresophageal reflux to antireflux surgery. Br J Surg 88: 1649–1652PubMedCrossRefGoogle Scholar
  12. 12.
    Dobhan R, Castell DO (1993) Normal and abnormal proximal esophageal acid exposure: results of ambulatory dual-probe pH monitoring. Am J Gastroenterol 88: 25–29PubMedGoogle Scholar
  13. 13.
    Jamieson JR, Stein HJ, DeMeester TR, Bonavina L, Schwizer W, Hinder RA, Albertucci M (1992) Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 87: 1102–1111PubMedGoogle Scholar
  14. 14.
    Oelschlager BK, Eubanks TR, Maronian N, Hillel A, Oleynikov D, Pope CE, Pellegrini CA (2002) Laryngoscopy and pharyngeal pH are complementary in the diagnosis of gastroesophageal–laryngeal reflux. J Gastrointest Surg 6: 189–194PubMedCrossRefGoogle Scholar
  15. 15.
    Allen CJ, Anvari M (2004) Does laparoscopic fundoplication provide long-term control of gastroesophageal reflux related cough? Surg Endosc 18: 633–637PubMedCrossRefGoogle Scholar
  16. 16.
    Patti MG, Arcerito M, Tamburini A, Diener U, Feo CV, Safadi B, Fisichella P, Way LW (2000) Effect of laparoscopic fundoplication on gastroesophageal reflux disease–induced respiratory symptoms. J Gastrointest Surg 4: 143–149PubMedCrossRefGoogle Scholar
  17. 17.
    Brouwer R, Kiroff GK (2003) Improvement of respiratory symptoms following laparoscopic Nissen fundoplication. ANZ J Surg;73: 189–193PubMedCrossRefGoogle Scholar
  18. 18.
    Reavis KM, Morris CD, Gopal DV, Hunter JG, Jobe BA (2004) Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms. Ann Surg 239: 849–856, discussion 56–58PubMedCrossRefGoogle Scholar
  19. 19.
    Booth MI, Jones L, Stratford J, Dehn TC (2002) Results of laparoscopic Nissen fundoplication at 2–8 years after surgery. Br J Surg 89: 476–481PubMedCrossRefGoogle Scholar
  20. 20.
    Oelschlager BK, Pellegrini CA (2001) Minimally invasive surgery for gastroesophageal reflux disease. J Lap Adv Surg Tech 11: 341–349CrossRefGoogle Scholar
  21. 21.
    Dassinger MS, Torquati A, Houston HL, Holzman MD, Sharp KW, Richards WO (2004) Laparoscopic fundoplication: 5-year follow-up. Am Surg 70: 691–694, discussion 4–5PubMedGoogle Scholar
  22. 22.
    Stein MR (2003) Possible mechanisms of influence of esophageal acid on airway hyperresponsiveness. Am J Med 115(Suppl 3A): 55S–59SPubMedCrossRefGoogle Scholar
  23. 23.
    Sullivan SD (2003) Asthma in the United States: recent trends and current status. J Manage Care Pharm 9(5 Suppl): 3–7Google Scholar
  24. 24.
    Redd SC (2002) Asthma in the United States: burden and current theories. Environ Health Perspect 110(Suppl 4): 557–560PubMedGoogle Scholar
  25. 25.
    LeNoir MA (1999) Asthma in inner cities. J Natl Med Assoc 91(8 Suppl): 1S–8SPubMedGoogle Scholar
  26. 26.
    Berger WE (2003) Overview of allergic rhinitis. Ann Allergy Asthma Immunol 90(6 Suppl 3): 7–12PubMedCrossRefGoogle Scholar
  27. 27.
    Irwin RS, Zawacki JK, Wilson MM, French CT, Callery MP (2002) Chronic cough due to gastroesophageal reflux disease: failure to resolve despite total/near-total elimination of esophageal acid. Chest 121: 1132–1140PubMedCrossRefGoogle Scholar
  28. 28.
    Wetscher GJ, Glaser K, Hinder RA, Perdikis G, Klingler P, Bammer T, Wieschemeyer T, Schwab G, Klinger A, Pointner R (1997) Respiratory symptoms in patients with gastroesophageal reflux disease following medical therapy and following antireflux surgery. Am J Surg 174: 639–642, discussion 42–43PubMedCrossRefGoogle Scholar
  29. 29.
    Sontag SJ, O’Connell S, Khandelwal S, Greenlee H, Schnell T, Nemchausky B, Chejfec G, Miller T, Seidel J, Sonnenberg A (2003) Asthmatics with gastroesophageal reflux: long-term results of a randomized trial of medical and surgical antireflux therapies. Am J Gastroenterol 98: 987–999PubMedGoogle Scholar
  30. 30.
    Hongo M (2005) Reflux or reflex in GERD-related asthma. J Gastroenterol 40: 109–110PubMedCrossRefGoogle Scholar
  31. 31.
    Siegel PD, Katz J (1996) Respiratory complications of gastroesophageal reflux disease. Prim Care 23: 433–441PubMedGoogle Scholar
  32. 32.
    Todd JA, Basu KK, de Caestecker JS (2005) Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett’s oesophagus. Aliment Pharmacol Ther 21: 969–975PubMedCrossRefGoogle Scholar
  33. 33.
    Gerson LB, Boparai V, Ullah N, Triadafilopoulos G (2004) Oesophageal and gastric pH profiles in patients with gastroesophageal reflux disease and Barrett’s esophagus treated with proton pump inhibitors. Aliment Pharmacol Ther 20: 637–643PubMedCrossRefGoogle Scholar
  34. 34.
    Tutuian R, Castell DO (2003) Use of multichannel intraluminal impedance to document proximal esophageal and pharyngeal nonacidic reflux episodes. Am J Med 115(Suppl 3A): 119S–123SPubMedCrossRefGoogle Scholar
  35. 35.
    Dobhan RCD (1993) Normal and abnormal proximal esophageal acid exposure: results of ambulatory dual-probe pH monitoring. Am J Gastroenterol 88: 25–29PubMedGoogle Scholar
  36. 36.
    Weiner GJ, Morgan MT, Copper JB, Wu WC, Castell DO, Sinclair JW, Richter JE (1988) Ambulatory 24-hour esophageal pH monitoring: reproducibility and variability of pH parameters. Dig Dis Sci 33: 1127–1133CrossRefGoogle Scholar
  37. 37.
    Madan K, Ahuja V, Gupta SD, Bal C, Kapoor A, Sharma MP (2005) Impact of 24-h esophageal pH monitoring on the diagnosis of gastroesophageal reflux disease: defining the gold standard. J Gastroenterol Hepatol 20: 30–37PubMedCrossRefGoogle Scholar
  38. 38.
    Katz PO (1990) Ambulatory esophageal and hypopharyngeal pH monitoring in patients with hoarseness. Am J Gastroenterol 85: 38–40PubMedGoogle Scholar
  39. 39.
    Roka R, Rosztoczy A, Izbeki F, Taybani Z, Kiss I, Lonovics J, Wittmann T (2005) Prevalence of respiratory symptoms and diseases associated with gastroesophageal reflux disease. Digestion 71: 92–96PubMedCrossRefGoogle Scholar
  40. 40.
    Eubanks TR, Omelanczuk PE, Maronian N, Hillel A, Pope CE II, Pellegrini CA (2001) Pharyngeal pH monitoring in 222 patients with suspected laryngeal reflux. J Gastrointest Surg 5: 183–190, discussion 90–91PubMedCrossRefGoogle Scholar
  41. 41.
    Eubanks TR, Omelanczuk P, Hillel A, Maronian N, Pope CE, Pellegrini CA (2001) Pharyngeal pH measurements in patients with respiratory symptoms prior to and during proton pump inhibitor therapy. Am J Surg 181: 466–470PubMedCrossRefGoogle Scholar
  42. 42.
    Oelschlager BK, Eubanks TR, Oleynikov D, Pope C, Pellegrini CA (2002) Symptomatic and physiologic outcomes after operative treatment for extraesophageal reflux. Surg Endosc 16: 1032–1036PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • J. A. Kaufman
    • 1
  • J. E. Houghland
    • 1
  • E. Quiroga
    • 1
  • M. Cahill
    • 1
  • C. A. Pellegrini
    • 1
  • B. K. Oelschlager
    • 1
  1. 1.Department of SurgeryUniversity of WashingtonSeattleUSA

Personalised recommendations